Acticor Biotech (XPAR:ALACT) Accumulated Depreciation : €-0.04 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Acticor Biotech's quarterly accumulated depreciation declined from Jun. 2022 (€-0.34 Mil) to Dec. 2022 (€-0.07 Mil) but then stayed the same from Dec. 2022 (€-0.07 Mil) to Jun. 2023 (€-0.04 Mil).

Acticor Biotech's annual accumulated depreciation increased from Dec. 2020 (€-0.20 Mil) to Dec. 2021 (€-0.29 Mil) but then stayed the same from Dec. 2021 (€-0.29 Mil) to Dec. 2022 (€-0.07 Mil).

Acticor Biotech Accumulated Depreciation Historical Data

The historical data trend for Acticor Biotech's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Accumulated Depreciation Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accumulated Depreciation

Get a 7-Day Free Trial

-0.03

-0.11

-0.20

-0.29

-0.07

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Accumulated Depreciation	Get a 7-Day Free Trial				-0.25	-0.29	-0.34	-0.07	-0.04

Acticor Biotech Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Acticor Biotech Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines